Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease

NCT01448850 is registered in ClinicalTrials.gov with MedImmune LLC as lead sponsor.

NCT NCT01448850
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01448850 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Double-blind, Placebo-controlled Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease
Lead sponsor
MedImmune LLC
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2011
Completion date
February 28, 2014
Enrollment
464 (actual)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease